Crossmark

FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21

Crossref DOI link: https://doi.org/10.1186/s13046-019-1058-6

Published Online: 2019-02-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Long

Chen, Jin

Ning, Deng

Liu, Qiumeng

Wang, Chao

Zhang, Zhaoqi

Chu, Liang

Yu, Chengpeng

Liang, Hui-fang

Zhang, Bixiang

Chen, Xiaoping
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31671348)

National Natural Science Foundation of China (81572855)

National Natural Science Foundation of China (81572427)

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (2018ZX10723204-003)

Natural Science Foundation of Hubei Province (2015CFB462)

National Natural Science Foundation of China (81874189)
License Information

Text and Data Mining valid from 2019-02-26
More Information

Article History

Received: 5 November 2018

Accepted: 27 January 2019

First Online: 26 February 2019

Ethics approval and consent to participate

: All procedures performed in this study involving human participants and animals were approved by the Ethics Committee of Tongji Hospital. Signed informed consent was obtained from each patient.

: Informed consent was obtained from all individual participants included in the study.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.